TCPE_HUMAN - dbPTM
TCPE_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TCPE_HUMAN
UniProt AC P48643
Protein Name T-complex protein 1 subunit epsilon
Gene Name CCT5
Organism Homo sapiens (Human).
Sequence Length 541
Subcellular Localization Cytoplasm . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome .
Protein Description Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. As part of the BBS/CCT complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Known to play a role, in vitro, in the folding of actin and tubulin..
Protein Sequence MASMGTLAFDEYGRPFLIIKDQDRKSRLMGLEALKSHIMAAKAVANTMRTSLGPNGLDKMMVDKDGDVTVTNDGATILSMMDVDHQIAKLMVELSKSQDDEIGDGTTGVVVLAGALLEEAEQLLDRGIHPIRIADGYEQAARVAIEHLDKISDSVLVDIKDTEPLIQTAKTTLGSKVVNSCHRQMAEIAVNAVLTVADMERRDVDFELIKVEGKVGGRLEDTKLIKGVIVDKDFSHPQMPKKVEDAKIAILTCPFEPPKPKTKHKLDVTSVEDYKALQKYEKEKFEEMIQQIKETGANLAICQWGFDDEANHLLLQNNLPAVRWVGGPEIELIAIATGGRIVPRFSELTAEKLGFAGLVQEISFGTTKDKMLVIEQCKNSRAVTIFIRGGNKMIIEEAKRSLHDALCVIRNLIRDNRVVYGGGAAEISCALAVSQEADKCPTLEQYAMRAFADALEVIPMALSENSGMNPIQTMTEVRARQVKEMNPALGIDCLHKGTNDMKQQHVIETLIGKKQQISLATQMVRMILKIDDIRKPGESEE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MASMGTLAF
------CCCCCCEEE
14.2819413330
3Phosphorylation-----MASMGTLAFD
-----CCCCCCEEEC
19.2220068231
4Sulfoxidation----MASMGTLAFDE
----CCCCCCEEECC
3.2728183972
6Phosphorylation--MASMGTLAFDEYG
--CCCCCCEEECCCC
13.2820068231
12PhosphorylationGTLAFDEYGRPFLII
CCEEECCCCCEEEEE
21.9320068231
20SumoylationGRPFLIIKDQDRKSR
CCEEEEEECCCHHHH
42.2028112733
20UbiquitinationGRPFLIIKDQDRKSR
CCEEEEEECCCHHHH
42.20-
25UbiquitinationIIKDQDRKSRLMGLE
EEECCCHHHHHCCHH
48.49-
26PhosphorylationIKDQDRKSRLMGLEA
EECCCHHHHHCCHHH
31.3830266825
27MethylationKDQDRKSRLMGLEAL
ECCCHHHHHCCHHHH
31.56-
29SulfoxidationQDRKSRLMGLEALKS
CCHHHHHCCHHHHHH
5.8321406390
35UbiquitinationLMGLEALKSHIMAAK
HCCHHHHHHHHHHHH
47.2221890473
35UbiquitinationLMGLEALKSHIMAAK
HCCHHHHHHHHHHHH
47.2221890473
35AcetylationLMGLEALKSHIMAAK
HCCHHHHHHHHHHHH
47.2225953088
35UbiquitinationLMGLEALKSHIMAAK
HCCHHHHHHHHHHHH
47.2221890473
39SulfoxidationEALKSHIMAAKAVAN
HHHHHHHHHHHHHHH
2.1930846556
42SumoylationKSHIMAAKAVANTMR
HHHHHHHHHHHHHHH
33.58-
42SumoylationKSHIMAAKAVANTMR
HHHHHHHHHHHHHHH
33.58-
42UbiquitinationKSHIMAAKAVANTMR
HHHHHHHHHHHHHHH
33.5821906983
49MethylationKAVANTMRTSLGPNG
HHHHHHHHHCCCCCC
21.08-
50PhosphorylationAVANTMRTSLGPNGL
HHHHHHHHCCCCCCH
19.9229449344
51PhosphorylationVANTMRTSLGPNGLD
HHHHHHHCCCCCCHH
22.4425159151
57UbiquitinationTSLGPNGLDKMMVDK
HCCCCCCHHCEEECC
7.90-
59AcetylationLGPNGLDKMMVDKDG
CCCCCHHCEEECCCC
33.6627452117
59UbiquitinationLGPNGLDKMMVDKDG
CCCCCHHCEEECCCC
33.66-
64AcetylationLDKMMVDKDGDVTVT
HHCEEECCCCCEEEE
52.8012649881
64UbiquitinationLDKMMVDKDGDVTVT
HHCEEECCCCCEEEE
52.80-
67AcetylationMMVDKDGDVTVTNDG
EEECCCCCEEEECCC
42.94-
67UbiquitinationMMVDKDGDVTVTNDG
EEECCCCCEEEECCC
42.94-
69PhosphorylationVDKDGDVTVTNDGAT
ECCCCCEEEECCCCE
26.7621406692
71PhosphorylationKDGDVTVTNDGATIL
CCCCEEEECCCCEEE
20.4421406692
76PhosphorylationTVTNDGATILSMMDV
EEECCCCEEEEECCH
28.1621406692
77UbiquitinationVTNDGATILSMMDVD
EECCCCEEEEECCHH
2.38-
79PhosphorylationNDGATILSMMDVDHQ
CCCCEEEEECCHHHH
14.2821406692
83UbiquitinationTILSMMDVDHQIAKL
EEEEECCHHHHHHHH
3.73-
117UbiquitinationVVLAGALLEEAEQLL
HHHCHHHHHHHHHHH
5.76-
121UbiquitinationGALLEEAEQLLDRGI
HHHHHHHHHHHHCCC
45.07-
130AcetylationLLDRGIHPIRIADGY
HHHCCCCCEEECCCH
18.68-
130UbiquitinationLLDRGIHPIRIADGY
HHHCCCCCEEECCCH
18.68-
130AcetylationLLDRGIHPIRIADGY
HHHCCCCCEEECCCH
18.6819608861
130UbiquitinationLLDRGIHPIRIADGY
HHHCCCCCEEECCCH
18.6819608861
132MethylationDRGIHPIRIADGYEQ
HCCCCCEEECCCHHH
23.61-
133UbiquitinationRGIHPIRIADGYEQA
CCCCCEEECCCHHHH
4.19-
137PhosphorylationPIRIADGYEQAARVA
CEEECCCHHHHHHHH
12.8628152594
139AcetylationRIADGYEQAARVAIE
EECCCHHHHHHHHHH
31.66-
139UbiquitinationRIADGYEQAARVAIE
EECCCHHHHHHHHHH
31.66-
139AcetylationRIADGYEQAARVAIE
EECCCHHHHHHHHHH
31.6619608861
139UbiquitinationRIADGYEQAARVAIE
EECCCHHHHHHHHHH
31.6619608861
149UbiquitinationRVAIEHLDKISDSVL
HHHHHHHHHCCCEEE
48.42-
1502-HydroxyisobutyrylationVAIEHLDKISDSVLV
HHHHHHHHCCCEEEE
50.93-
150UbiquitinationVAIEHLDKISDSVLV
HHHHHHHHCCCEEEE
50.9321906983
152PhosphorylationIEHLDKISDSVLVDI
HHHHHHCCCEEEEEC
29.5830266825
154UbiquitinationHLDKISDSVLVDIKD
HHHHCCCEEEEECCC
15.57-
154PhosphorylationHLDKISDSVLVDIKD
HHHHCCCEEEEECCC
15.5730266825
160SumoylationDSVLVDIKDTEPLIQ
CEEEEECCCCHHHHH
54.88-
1602-HydroxyisobutyrylationDSVLVDIKDTEPLIQ
CEEEEECCCCHHHHH
54.88-
160AcetylationDSVLVDIKDTEPLIQ
CEEEEECCCCHHHHH
54.8823954790
160SumoylationDSVLVDIKDTEPLIQ
CEEEEECCCCHHHHH
54.88-
160UbiquitinationDSVLVDIKDTEPLIQ
CEEEEECCCCHHHHH
54.8821906983
168UbiquitinationDTEPLIQTAKTTLGS
CCHHHHHHHHHHHCH
24.11-
168PhosphorylationDTEPLIQTAKTTLGS
CCHHHHHHHHHHHCH
24.11-
170UbiquitinationEPLIQTAKTTLGSKV
HHHHHHHHHHHCHHH
45.49-
1702-HydroxyisobutyrylationEPLIQTAKTTLGSKV
HHHHHHHHHHHCHHH
45.49-
170AcetylationEPLIQTAKTTLGSKV
HHHHHHHHHHHCHHH
45.4925953088
170MalonylationEPLIQTAKTTLGSKV
HHHHHHHHHHHCHHH
45.4926320211
170UbiquitinationEPLIQTAKTTLGSKV
HHHHHHHHHHHCHHH
45.49-
171UbiquitinationPLIQTAKTTLGSKVV
HHHHHHHHHHCHHHH
25.4521890473
172AcetylationLIQTAKTTLGSKVVN
HHHHHHHHHCHHHHH
28.54-
172UbiquitinationLIQTAKTTLGSKVVN
HHHHHHHHHCHHHHH
28.54-
176SumoylationAKTTLGSKVVNSCHR
HHHHHCHHHHHHHHH
48.69-
1762-HydroxyisobutyrylationAKTTLGSKVVNSCHR
HHHHHCHHHHHHHHH
48.69-
176AcetylationAKTTLGSKVVNSCHR
HHHHHCHHHHHHHHH
48.6926051181
176SumoylationAKTTLGSKVVNSCHR
HHHHHCHHHHHHHHH
48.69-
176UbiquitinationAKTTLGSKVVNSCHR
HHHHHCHHHHHHHHH
48.69-
177UbiquitinationKTTLGSKVVNSCHRQ
HHHHCHHHHHHHHHH
5.4421890473
181S-nitrosocysteineGSKVVNSCHRQMAEI
CHHHHHHHHHHHHHH
2.30-
181S-nitrosylationGSKVVNSCHRQMAEI
CHHHHHHHHHHHHHH
2.3019483679
182AcetylationSKVVNSCHRQMAEIA
HHHHHHHHHHHHHHH
23.87-
182UbiquitinationSKVVNSCHRQMAEIA
HHHHHHHHHHHHHHH
23.87-
186AcetylationNSCHRQMAEIAVNAV
HHHHHHHHHHHHHHH
9.19-
189UbiquitinationHRQMAEIAVNAVLTV
HHHHHHHHHHHHEHH
4.68-
191UbiquitinationQMAEIAVNAVLTVAD
HHHHHHHHHHEHHHH
18.47-
210UbiquitinationDVDFELIKVEGKVGG
CCCEEEEEEECEECC
47.0221890473
210SumoylationDVDFELIKVEGKVGG
CCCEEEEEEECEECC
47.02-
2102-HydroxyisobutyrylationDVDFELIKVEGKVGG
CCCEEEEEEECEECC
47.02-
210AcetylationDVDFELIKVEGKVGG
CCCEEEEEEECEECC
47.0226051181
210SumoylationDVDFELIKVEGKVGG
CCCEEEEEEECEECC
47.0228112733
210UbiquitinationDVDFELIKVEGKVGG
CCCEEEEEEECEECC
47.0221906983
214SumoylationELIKVEGKVGGRLED
EEEEEECEECCCCCC
24.9728112733
214UbiquitinationELIKVEGKVGGRLED
EEEEEECEECCCCCC
24.9721906983
220UbiquitinationGKVGGRLEDTKLIKG
CEECCCCCCCEEEEE
63.3721890473
2232-HydroxyisobutyrylationGGRLEDTKLIKGVIV
CCCCCCCEEEEEEEE
61.61-
223AcetylationGGRLEDTKLIKGVIV
CCCCCCCEEEEEEEE
61.6123749302
223MalonylationGGRLEDTKLIKGVIV
CCCCCCCEEEEEEEE
61.6126320211
223UbiquitinationGGRLEDTKLIKGVIV
CCCCCCCEEEEEEEE
61.6119608861
226UbiquitinationLEDTKLIKGVIVDKD
CCCCEEEEEEEECCC
58.5221890473
226SumoylationLEDTKLIKGVIVDKD
CCCCEEEEEEEECCC
58.52-
2262-HydroxyisobutyrylationLEDTKLIKGVIVDKD
CCCCEEEEEEEECCC
58.52-
226AcetylationLEDTKLIKGVIVDKD
CCCCEEEEEEEECCC
58.5227452117
226MalonylationLEDTKLIKGVIVDKD
CCCCEEEEEEEECCC
58.5226320211
226SumoylationLEDTKLIKGVIVDKD
CCCCEEEEEEEECCC
58.52-
226UbiquitinationLEDTKLIKGVIVDKD
CCCCEEEEEEEECCC
58.5221890473
229UbiquitinationTKLIKGVIVDKDFSH
CEEEEEEEECCCCCC
4.5221890473
232UbiquitinationIKGVIVDKDFSHPQM
EEEEEECCCCCCCCC
50.1821890473
2322-HydroxyisobutyrylationIKGVIVDKDFSHPQM
EEEEEECCCCCCCCC
50.18-
232AcetylationIKGVIVDKDFSHPQM
EEEEEECCCCCCCCC
50.1823749302
232UbiquitinationIKGVIVDKDFSHPQM
EEEEEECCCCCCCCC
50.1821890473
235PhosphorylationVIVDKDFSHPQMPKK
EEECCCCCCCCCCCC
44.3720860994
239SulfoxidationKDFSHPQMPKKVEDA
CCCCCCCCCCCHHCC
6.5630846556
2412-HydroxyisobutyrylationFSHPQMPKKVEDAKI
CCCCCCCCCHHCCEE
65.20-
242AcetylationSHPQMPKKVEDAKIA
CCCCCCCCHHCCEEE
45.017379973
2472-HydroxyisobutyrylationPKKVEDAKIAILTCP
CCCHHCCEEEEEECC
45.02-
247UbiquitinationPKKVEDAKIAILTCP
CCCHHCCEEEEEECC
45.02-
253GlutathionylationAKIAILTCPFEPPKP
CEEEEEECCCCCCCC
3.0522555962
253S-palmitoylationAKIAILTCPFEPPKP
CEEEEEECCCCCCCC
3.0529575903
259UbiquitinationTCPFEPPKPKTKHKL
ECCCCCCCCCCCCCC
70.62-
259AcetylationTCPFEPPKPKTKHKL
ECCCCCCCCCCCCCC
70.6226051181
259MalonylationTCPFEPPKPKTKHKL
ECCCCCCCCCCCCCC
70.6226320211
259UbiquitinationTCPFEPPKPKTKHKL
ECCCCCCCCCCCCCC
70.62-
261AcetylationPFEPPKPKTKHKLDV
CCCCCCCCCCCCCCC
76.0811789789
261MalonylationPFEPPKPKTKHKLDV
CCCCCCCCCCCCCCC
76.0826320211
261UbiquitinationPFEPPKPKTKHKLDV
CCCCCCCCCCCCCCC
76.08-
263AcetylationEPPKPKTKHKLDVTS
CCCCCCCCCCCCCCC
44.8911789799
263UbiquitinationEPPKPKTKHKLDVTS
CCCCCCCCCCCCCCC
44.89-
265UbiquitinationPKPKTKHKLDVTSVE
CCCCCCCCCCCCCHH
48.1921890473
265SumoylationPKPKTKHKLDVTSVE
CCCCCCCCCCCCCHH
48.19-
2652-HydroxyisobutyrylationPKPKTKHKLDVTSVE
CCCCCCCCCCCCCHH
48.19-
265AcetylationPKPKTKHKLDVTSVE
CCCCCCCCCCCCCHH
48.1923954790
265SumoylationPKPKTKHKLDVTSVE
CCCCCCCCCCCCCHH
48.1928112733
265UbiquitinationPKPKTKHKLDVTSVE
CCCCCCCCCCCCCHH
48.1921890473
269PhosphorylationTKHKLDVTSVEDYKA
CCCCCCCCCHHHHHH
27.0729978859
270PhosphorylationKHKLDVTSVEDYKAL
CCCCCCCCHHHHHHH
24.2921815630
274PhosphorylationDVTSVEDYKALQKYE
CCCCHHHHHHHHHHH
5.6726074081
275UbiquitinationVTSVEDYKALQKYEK
CCCHHHHHHHHHHHH
55.7521890473
275UbiquitinationVTSVEDYKALQKYEK
CCCHHHHHHHHHHHH
55.75-
275AcetylationVTSVEDYKALQKYEK
CCCHHHHHHHHHHHH
55.7523236377
275SumoylationVTSVEDYKALQKYEK
CCCHHHHHHHHHHHH
55.7528112733
275UbiquitinationVTSVEDYKALQKYEK
CCCHHHHHHHHHHHH
55.7521890473
277UbiquitinationSVEDYKALQKYEKEK
CHHHHHHHHHHHHHH
3.84-
279SumoylationEDYKALQKYEKEKFE
HHHHHHHHHHHHHHH
57.11-
2792-HydroxyisobutyrylationEDYKALQKYEKEKFE
HHHHHHHHHHHHHHH
57.11-
279AcetylationEDYKALQKYEKEKFE
HHHHHHHHHHHHHHH
57.1123749302
279SumoylationEDYKALQKYEKEKFE
HHHHHHHHHHHHHHH
57.1128112733
279UbiquitinationEDYKALQKYEKEKFE
HHHHHHHHHHHHHHH
57.11-
280PhosphorylationDYKALQKYEKEKFEE
HHHHHHHHHHHHHHH
21.1926074081
282AcetylationKALQKYEKEKFEEMI
HHHHHHHHHHHHHHH
64.2125953088
282UbiquitinationKALQKYEKEKFEEMI
HHHHHHHHHHHHHHH
64.21-
284UbiquitinationLQKYEKEKFEEMIQQ
HHHHHHHHHHHHHHH
69.9721890473
284AcetylationLQKYEKEKFEEMIQQ
HHHHHHHHHHHHHHH
69.9725953088
284UbiquitinationLQKYEKEKFEEMIQQ
HHHHHHHHHHHHHHH
69.9721906983
285UbiquitinationQKYEKEKFEEMIQQI
HHHHHHHHHHHHHHH
11.44-
288SulfoxidationEKEKFEEMIQQIKET
HHHHHHHHHHHHHHH
2.3621406390
299UbiquitinationIKETGANLAICQWGF
HHHHCCCEEEEECCC
3.18-
306UbiquitinationLAICQWGFDDEANHL
EEEEECCCCHHHHHH
11.03-
306AcetylationLAICQWGFDDEANHL
EEEEECCCCHHHHHH
11.0319608861
306UbiquitinationLAICQWGFDDEANHL
EEEEECCCCHHHHHH
11.0319608861
346UbiquitinationGRIVPRFSELTAEKL
CCEECCHHHHHHHHH
32.73-
346PhosphorylationGRIVPRFSELTAEKL
CCEECCHHHHHHHHH
32.7325850435
352UbiquitinationFSELTAEKLGFAGLV
HHHHHHHHHCCCCEE
51.99-
363PhosphorylationAGLVQEISFGTTKDK
CCEEEEECCCCCCCC
19.5128348404
368UbiquitinationEISFGTTKDKMLVIE
EECCCCCCCCEEEEE
56.0121906983
3702-HydroxyisobutyrylationSFGTTKDKMLVIEQC
CCCCCCCCEEEEEEC
35.37-
370AcetylationSFGTTKDKMLVIEQC
CCCCCCCCEEEEEEC
35.3727452117
370UbiquitinationSFGTTKDKMLVIEQC
CCCCCCCCEEEEEEC
35.37-
371SulfoxidationFGTTKDKMLVIEQCK
CCCCCCCEEEEEECC
5.3221406390
377GlutathionylationKMLVIEQCKNSRAVT
CEEEEEECCCCCEEE
2.6722555962
377S-nitrosylationKMLVIEQCKNSRAVT
CEEEEEECCCCCEEE
2.672212679
3782-HydroxyisobutyrylationMLVIEQCKNSRAVTI
EEEEEECCCCCEEEE
58.62-
378AcetylationMLVIEQCKNSRAVTI
EEEEEECCCCCEEEE
58.6225953088
378UbiquitinationMLVIEQCKNSRAVTI
EEEEEECCCCCEEEE
58.6221906983
390UbiquitinationVTIFIRGGNKMIIEE
EEEEEECCCEEHHHH
22.27-
3922-HydroxyisobutyrylationIFIRGGNKMIIEEAK
EEEECCCEEHHHHHH
34.45-
392AcetylationIFIRGGNKMIIEEAK
EEEECCCEEHHHHHH
34.4525953088
392SumoylationIFIRGGNKMIIEEAK
EEEECCCEEHHHHHH
34.4528112733
392UbiquitinationIFIRGGNKMIIEEAK
EEEECCCEEHHHHHH
34.4521906983
393SulfoxidationFIRGGNKMIIEEAKR
EEECCCEEHHHHHHH
4.2921406390
399AcetylationKMIIEEAKRSLHDAL
EEHHHHHHHHHHHHH
45.8819608861
399UbiquitinationKMIIEEAKRSLHDAL
EEHHHHHHHHHHHHH
45.8819608861
403AcetylationEEAKRSLHDALCVIR
HHHHHHHHHHHHHHH
21.39-
403UbiquitinationEEAKRSLHDALCVIR
HHHHHHHHHHHHHHH
21.39-
407S-nitrosocysteineRSLHDALCVIRNLIR
HHHHHHHHHHHHHHC
2.28-
407S-nitrosylationRSLHDALCVIRNLIR
HHHHHHHHHHHHHHC
2.2819483679
409UbiquitinationLHDALCVIRNLIRDN
HHHHHHHHHHHHCCC
2.06-
420UbiquitinationIRDNRVVYGGGAAEI
HCCCCEEECCCHHHH
13.75-
421UbiquitinationRDNRVVYGGGAAEIS
CCCCEEECCCHHHHH
19.22-
428UbiquitinationGGGAAEISCALAVSQ
CCCHHHHHHHHHHCC
5.7121890473
436UbiquitinationCALAVSQEADKCPTL
HHHHHCCCHHCCCHH
51.86-
439UbiquitinationAVSQEADKCPTLEQY
HHCCCHHCCCHHHHH
49.51-
440GlutathionylationVSQEADKCPTLEQYA
HCCCHHCCCHHHHHH
2.9922555962
442UbiquitinationQEADKCPTLEQYAMR
CCHHCCCHHHHHHHH
53.01-
459UbiquitinationADALEVIPMALSENS
HHHHHHHHHHHHCCC
13.7321890473
463PhosphorylationEVIPMALSENSGMNP
HHHHHHHHCCCCCCC
25.79-
466PhosphorylationPMALSENSGMNPIQT
HHHHHCCCCCCCCCH
35.05-
473PhosphorylationSGMNPIQTMTEVRAR
CCCCCCCHHHHHHHH
27.12-
474UbiquitinationGMNPIQTMTEVRARQ
CCCCCCHHHHHHHHH
1.4021890473
483UbiquitinationEVRARQVKEMNPALG
HHHHHHHHHHCHHCC
42.8021890473
483AcetylationEVRARQVKEMNPALG
HHHHHHHHHHCHHCC
42.8026051181
483UbiquitinationEVRARQVKEMNPALG
HHHHHHHHHHCHHCC
42.8021890473
485SulfoxidationRARQVKEMNPALGID
HHHHHHHHCHHCCCC
6.3621406390
493GlutathionylationNPALGIDCLHKGTND
CHHCCCCCCCCCCCH
3.9722555962
496AcetylationLGIDCLHKGTNDMKQ
CCCCCCCCCCCHHHH
55.2523749302
496UbiquitinationLGIDCLHKGTNDMKQ
CCCCCCCCCCCHHHH
55.25-
502SumoylationHKGTNDMKQQHVIET
CCCCCHHHHHHHHHH
50.06-
502AcetylationHKGTNDMKQQHVIET
CCCCCHHHHHHHHHH
50.0626822725
502SumoylationHKGTNDMKQQHVIET
CCCCCHHHHHHHHHH
50.06-
502UbiquitinationHKGTNDMKQQHVIET
CCCCCHHHHHHHHHH
50.0621906983
509PhosphorylationKQQHVIETLIGKKQQ
HHHHHHHHHHCHHHH
16.7320068231
5132-HydroxyisobutyrylationVIETLIGKKQQISLA
HHHHHHCHHHHHHHH
40.18-
513AcetylationVIETLIGKKQQISLA
HHHHHHCHHHHHHHH
40.1825953088
513UbiquitinationVIETLIGKKQQISLA
HHHHHHCHHHHHHHH
40.1821906983
514UbiquitinationIETLIGKKQQISLAT
HHHHHCHHHHHHHHH
42.0721890473
5142-HydroxyisobutyrylationIETLIGKKQQISLAT
HHHHHCHHHHHHHHH
42.07-
514UbiquitinationIETLIGKKQQISLAT
HHHHHCHHHHHHHHH
42.0721890473
518PhosphorylationIGKKQQISLATQMVR
HCHHHHHHHHHHHHH
13.9628258704
521PhosphorylationKQQISLATQMVRMIL
HHHHHHHHHHHHHHH
23.6121406692
523SulfoxidationQISLATQMVRMILKI
HHHHHHHHHHHHHCH
1.4728465586
529UbiquitinationQMVRMILKIDDIRKP
HHHHHHHCHHHCCCC
32.9121890473
5292-HydroxyisobutyrylationQMVRMILKIDDIRKP
HHHHHHHCHHHCCCC
32.91-
529AcetylationQMVRMILKIDDIRKP
HHHHHHHCHHHCCCC
32.9127452117
529UbiquitinationQMVRMILKIDDIRKP
HHHHHHHCHHHCCCC
32.9121890473
534MethylationILKIDDIRKPGESEE
HHCHHHCCCCCCCCC
46.22-
535AcetylationLKIDDIRKPGESEE-
HCHHHCCCCCCCCC-
58.6826051181
535UbiquitinationLKIDDIRKPGESEE-
HCHHHCCCCCCCCC-
58.682190698
539PhosphorylationDIRKPGESEE-----
HCCCCCCCCC-----
53.6025159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TCPE_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TCPE_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TCPE_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TBC17_HUMANTBC1D17physical
16169070
ELP1_HUMANIKBKAPphysical
16169070
MIC60_HUMANIMMTphysical
16169070
P53_HUMANTP53physical
16169070
THEG_HUMANTHEGphysical
10747865
GNB5_HUMANGNB5physical
19376773
GBB1_HUMANGNB1physical
19376773
RGS7_HUMANRGS7physical
19376773
TCPG_HUMANCCT3physical
22939629
TCPQ_HUMANCCT8physical
22939629
TCPZ_HUMANCCT6Aphysical
22939629
TCPH_HUMANCCT7physical
22939629
TCPW_HUMANCCT6Bphysical
22939629
TERA_HUMANVCPphysical
22939629
XPO1_HUMANXPO1physical
22939629
TXNL1_HUMANTXNL1physical
22939629
TIF1B_HUMANTRIM28physical
22939629
TCPB_HUMANCCT2physical
22863883
TCPQ_HUMANCCT8physical
22863883
ARP2_HUMANACTR2physical
26344197
TCPB_HUMANCCT2physical
26344197
TCPG_HUMANCCT3physical
26344197
TCPD_HUMANCCT4physical
26344197
TCPZ_HUMANCCT6Aphysical
26344197
TCPW_HUMANCCT6Bphysical
26344197
TCPH_HUMANCCT7physical
26344197
TCPQ_HUMANCCT8physical
26344197
TCPA_HUMANTCP1physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
256840Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive (HSNSP)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TCPE_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-223; LYS-232 AND LYS-399,AND MASS SPECTROMETRY.

TOP